Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Global Forecast 2024-2030


The Particle Therapy Market size was estimated at USD 772.41 million in 2023 and expected to reach USD 831.50 million in 2024, at a CAGR 7.94% to reach USD 1,318.87 million by 2030.

Global Particle Therapy MarketThe particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth. In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.Regional InsightsIn America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique. Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Particle Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Particle Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapy Type
Heavy Ion Therapy
Proton Therapy
Component
Product
Cyclotrons
Synchrocyclotrons
Synchrotrons
Service
Configuration
Multi-room System
Single-room System
Cancer Type
Breast Cancer
Head & Neck Cancer
Lung Cancer
Pediatric Cancer
Prostate Cancer
End-User
Ambulatory Surgery Centers
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Particle Therapy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Particle Therapy Market?
3. What are the technology trends and regulatory frameworks in the Particle Therapy Market?
4. What is the market share of the leading vendors in the Particle Therapy Market?
5. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Particle Therapy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advanced therapies in cancer treatment
5.1.1.2. Rise in adoption of particle therapy in clinical trials
5.1.1.3. Growing number of particle therapy centers worldwide
5.1.2. Restraints
5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
5.1.3. Opportunities
5.1.3.1. Ongoing proton therapy research programs
5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
5.1.4. Challenges
5.1.4.1. Risk associated with the particle therapy radiation exposure
5.2. Market Segmentation Analysis
5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Particle Therapy Market, by Therapy Type
6.1. Introduction
6.2. Heavy Ion Therapy
6.3. Proton Therapy
7. Particle Therapy Market, by Component
7.1. Introduction
7.2. Product
7.3.1. Cyclotrons
7.3.2. Synchrocyclotrons
7.3.3. Synchrotrons
7.3. Service
8. Particle Therapy Market, by Configuration
8.1. Introduction
8.2. Multi-room System
8.3. Single-room System
9. Particle Therapy Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Head & Neck Cancer
9.4. Lung Cancer
9.5. Pediatric Cancer
9.6. Prostate Cancer
10. Particle Therapy Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals & Clinics
11. Americas Particle Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Particle Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Particle Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
14.3.2. Investment & Funding
14.3.2.1. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
14.3.3. Award, Recognition, & Expansion
14.3.3.1. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Advanced Oncotherapy plc
15.1.2. B dot Medical Inc.
15.1.3. Best Particle Therapy, Inc.
15.1.4. BioSig Technologies Inc.
15.1.5. Covenant Health
15.1.6. Danfysik A/S
15.1.7. Elekta AB
15.1.8. Hitachi, Ltd.
15.1.9. IBA International
15.1.10. Koninklijke Philips N.V.
15.1.11. Mevion Medical Systems
15.1.12. Mitsubishi Electric Corporation
15.1.13. New Mexico Cancer Center
15.1.14. Optivus Proton Therapy, Inc.
15.1.15. P-Cure Ltd
15.1.16. ProTom International
15.1.17. Provision Healthcare, LLC
15.1.18. PTW Freiburg GmbH
15.1.19. SAH Global LLC
15.1.20. Shanghai APACTRON Particle Equipment Co., Ltd.
15.1.21. Siemens Healthineers GmbH
15.1.22. Stantec Inc.
15.1.23. Sumitomo Heavy Industries, Ltd.
15.1.24. Toshiba Medical Systems Corporation
15.1.25. Xstrahl Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
FIGURE 7. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 8. PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 10. PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
FIGURE 12. PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 14. PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings